Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Rekirona

European Medicines Agency (EMA) recommends using Celltrion’s Rekirona corona treatment

European Medicines Agency (EMA) recommends using Celltrion’s Rekirona corona treatment

CHMP “Celltrion Rekirona Can Be Used to Treat Corona 19”

CHMP “Celltrion Rekirona Can Be Used to Treat Corona 19”

EMA Celltrion Rekirona can be used for severely high-risk patients with COVID-19

EMA Celltrion Rekirona can be used for severely high-risk patients with COVID-19

EMA “Celltrion Rekirona, can be used for patients with severely high risk of COVID-19” (general)

EMA “Celltrion Rekirona, can be used for patients with severely high risk of COVID-19” (general)

EMA “Celltrion Rekirona, can be used for patients with severely high risk of COVID-19” (general)

European Medicines Agency “Celltrion Rekirona can be used to treat COVID-19”

Celltrion corona antibody treatment, Rekirona, opens its way to export to Europe

Celltrion corona antibody treatment, Rekirona, opens its way to export to Europe

[단독]EMA “Celltrion Rekirona State, Available for Emergency Use Before Permit in Europe”

[단독]EMA “Celltrion Rekirona State, Available for Emergency Use Before Permit in Europe”

Celltrion Rekirona is in front of Europe

Celltrion Rekirona is in front of Europe

Celltrion European Medicines Agency, Rekirona emergency use review begins

Celltrion European Medicines Agency, Rekirona emergency use review begins

Celltrion Rekirona State confirms ability to neutralize mutant virus in UK

Celltrion Rekirona State confirms ability to neutralize mutant virus in UK

[칼럼] Decision made after three-fold consultation with the Ministry of Food and Drug Safety Celltrion Rekirona State: Jeong Pil 正筆

[칼럼] Decision made after three-fold consultation with the Ministry of Food and Drug Safety Celltrion Rekirona State: Jeong Pil 正筆

[케이에스피뉴스] [칼럼]  Decision made after three-fold consultation with the Ministry of Food and Drug Safety’s Celltrion Rekirona State permit

[케이에스피뉴스] [칼럼] Decision made after three-fold consultation with the Ministry of Food and Drug Safety’s Celltrion Rekirona State permit

Older posts
Page1 Page2 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en